Immunoglobulin administration to fetuses with anemia due to alloimmunization to D

Transfusion

Volumn 39, Issue 11-12, 1999, Pages 1235-1238

  Ulm, B ^b   Kirchner, L ^b   Svolba, G ^b   Jilma, B ^b   Deutinger, J ^b   Bernaschek, G ^b   Panzer, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RHESUS D ANTIGEN;

ALLOIMMUNIZATION; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FETUS; HUMAN; IMMUNOTHERAPY; INTRAUTERINE BLOOD TRANSFUSION; INTRAVENOUS DRUG ADMINISTRATION; PRENATAL CARE; RHESUS ISOIMMUNIZATION;

FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY;

EID: 0032715315     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39111235.x     Document Type: Article

References (16)

1. Ulm B, Svolba G, Ulm MR, et al. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion 1999;39:169-73.
2. Ulm B, Ulm MR, Panzer S. Fetal sex and hemolytic disease from maternal red-cell alloimmunization. N Engl J Med 1998;338:1699-700.
3. Schumacher B, Moise KJ Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88:137-50.
4. Sacher RA, King JC. Intravenous gamma-globulin in pregnancy: a review. Obstet Gynecol Surv 1989;44:25-34.
5. Urbaniak SJ, Duncan JI, Armstrong-Fisher SS, et al. Transfer of anti-D antibodies across the isolated perfused human placental lobule and inhibition by high-dose intravenous immunoglobulin: a possible mechanism of action. Br J Haematol 1997;96:186-93.
6. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992;326:107-16.
7. de la Camara C, Arrieta R, Gonzalez A, et al. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 1988;318:519-20.
8. Margulies M, Voto LS, Mathet E, Margulies M. High-dose intravenous IgG for the treatment of severe Rhesus alloimmunization. Vox Sang 1991;61:181-9.
9. Gottvall T, Selbing A. Alloimmunization during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus. Acta Obstet Gynecol Scand 1995;74:777-83. in Rhesus incompatibility (letter). Lancet 1985;2:208.
10. Gottvall T, Selbing A. Alloimmunization during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus. Acta Obstet Gynecol Scand 1995;74:777-83. in Rhesus incompatibility (letter). Lancet 1985;2:208.
11. Rubo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992;121:93-7.
12. Voto LS, Sexer H, Ferreiro G, et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. J Perinat Med 1995;23:443-51.
13. Dooren MC, van Kamp IL, Scherpenisse JW, et al. No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic disease. Vox Sang 1994;66:253-7.
14. Nicolaides KH, Thorpe-Beeston JG, Salvesen DR, Snijders RJ. Fetal blood transfusion by cordocentesis. In: Chervenak FA, Isaacson GC, Campbell S, eds. Ultrasound in obstetrics and gynecology, vol 2. Boston: Little, Brown, 1993:1315-20.
15. Weiner CP, Williamson RA, Wenstrom KD, et al. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment. Am J Obstet Gynecol 1991;165:1302-7.
16. Bowman J. The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997;21:39-44.